Table 1.
DHD Anxiolytics | DHD Hypnotic-Sedatives | DHD Antidepressants | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Sex | Age Strata | COVID-19 Period | Pre-COVID-19 Period | Difference (%) | COVID-19 Period | Pre-COVID-19 Period | Difference (%) | COVID-19 Period | Pre-COVID-19 Period | Difference (%) |
Women | 25–34 | 17.8 | 14.2 | 25 | 3.1 | 2.7 | 15. | 21.2 | 18.9 | 12 |
35–44 | 42.6 | 36.9 | 15 | 9.6 | 8.6 | 11 | 44.8 | 45.0 | −0.4 | |
45–54 | 74.3 | 70.8 | 5.1 | 26.9 | 24.6 | 9.2 | 99.7 | 97.4 | 2.4 | |
55–64 | 119.6 | 111.7 | 7.1 | 59.5 | 57.3 | 3.9 | 165.6 | 160.4 | 3.3 | |
65–74 | 153.3 | 143.0 | 7.2 | 113.1 | 108.3 | 4.4 | 229.1 | 220.2 | 4.1 | |
75–84 | 171.4 | 142.3 | 20 | 170.5 | 169.1 | 0.8 | 286.0 | 278.3 | 2.8 | |
>84 | 146.7 | 136.0 | 7.9 | 211.1 | 194.5 | 8.6 | 842.9 | 811.2 | 3.9 | |
Total | 62.0 | 57.5 | 7.9 | 38.2 | 36.4 | 4.8 | 88.0 | 84.9 | 3.6 | |
Men | 25–34 | 11.9 | 11.6 | 2.8 | 2.8 | 1.9 | 46 | 8.9 | 8.7 | 2.2 |
35–44 | 27.3 | 27.3 | −0.1 | 5.0 | 4.8 | 5.2 | 18.2 | 17.9 | 1.3 | |
45–54 | 59.2 | 56.3 | 5.2 | 14.4 | 12.9 | 12 | 34.8 | 32.0 | 8.8 | |
55–64 | 64.6 | 58.1 | 11 | 31.5 | 29.0 | 8.5 | 59.4 | 57.2 | 3.9 | |
65–74 | 66.3 | 61.4 | 8.0 | 60.4 | 57.5 | 5.0 | 63.2 | 61.5 | 2.9 | |
75–84 | 74.3 | 72.5 | 2.4 | 96.9 | 92.7 | 4.6 | 101.5 | 99.3 | 2.2 | |
>84 | 82.7 | 74.6 | 11 | 120.1 | 113.2 | 6.0 | 112.3 | 108.9 | 3.1 | |
Total | 32.7 | 30.8 | 6. | 17.1 | 16.0 | 7.2 | 27.3 | 26.3 | 3.9 |